thymidine 5'-diphosphate has been researched along with ag 2000 in 1 studies
| Studies (thymidine 5'-diphosphate) | Trials (thymidine 5'-diphosphate) | Recent Studies (post-2010) (thymidine 5'-diphosphate) | Studies (ag 2000) | Trials (ag 2000) | Recent Studies (post-2010) (ag 2000) |
|---|---|---|---|---|---|
| 23 | 0 | 3 | 7 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dinkhauser, P; Fürst, J; Gschwentner, M; Laich, A; Lang, F; Paulmichl, M; Ritter, M; Rossmann, H; Scandella, E; Schmarda, A; Seidler, U; Wöll, E | 1 |
1 other study(ies) available for thymidine 5'-diphosphate and ag 2000
| Article | Year |
|---|---|
The gastric H,K-ATPase blocker lansoprazole is an inhibitor of chloride channels.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; 3T3 Cells; Animals; Benzimidazoles; Cell Size; Chloride Channels; Dithiothreitol; Electrophysiology; Enzyme Inhibitors; Fibroblasts; Lansoprazole; Mice; Omeprazole; Proton Pump Inhibitors; Pyridines; Stomach; Sulfhydryl Reagents; Thymine Nucleotides | 2000 |